McKane 1987.

Methods	Allocation: randomised. Blindness: double. Duration: 60 weeks (preceded by 12 week 'run in' period where additional medication allowed).
Participants	Diagnosis: schizophrenia (Fiegner criteria*). History: on antipsychotics, duration ill ‐ mean 31 yrs, range 10‐50, next of kin gave consent. N=38. Age: mean 56 yrs, range 31‐ 71. Sex : 22 M, 16 F. Setting: in hospital.
Interventions	1. Haloperidol decanaote: initial dose mean 127 mg/injection, week 12 dose mean 120mg/ injection, monthly. N=17. 2. Fluphenazine decanoate: initial mean dose 106mg/ injection, week 12 dose mean 105/ injection, monthly. N=16.
Outcomes	Mental state (Krawiecka scale). Leaving the study early. Additional medication. Side effects (AIMS). Parkinsonism (Simpson & Angus). Behaviour (Wing Ward Behaviour Scale). Unable to use ‐ Global impresson (Global 5‐point scale ‐ no data). Physiological measures (prolactin, drug plasma levels ‐ non clinical outcomes, data not usable).
Notes	* Fiegner 1972
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear